Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06335173
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-03-13
Brief Title:
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimers Disease ALTITUDE-AD
Sponsor:
Acumen Pharmaceuticals
Organization:
Acumen Pharmaceuticals